Healthcare products company unveils new brand identity and introduces Silkura, a revolutionary silicone-based ostomy pouch ...

Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced the ...

MINNEAPOLIS, April 24, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, today announced that it will report its financial results for the ...

Ruling preserves current contracted royalty rates and rejects Tesaro’s request for any royalty reduction; Trial to adjudicate Anaptys’ contract claims and right to seek revers ...

All product details are based on provided official Performance Lab materials and should be verified on the official website before any purchasing decision. These statements have not been evaluated by ...

Paris, April 24, 2026 - Sanofi announces that it has successfully priced its offering of €2.3 billion of notes across 3 tranches: €1,000 million fixed-rate notes, due May 2029, bearing interest at an ...

Paraxanthine is the metabolite the human liver produces when it breaks down caffeine. Recent peer-reviewed research identifies paraxanthine as the molecule responsible for much of caffeine's cognitive ...

President Trump on April 18 issued an Executive Order directing the U.S. Department of Health and Human Services to accelerate access to treatments for patients with serious mental illness, including ...

Annual Shareholder Meeting to be held at 10:00 am PT on June 17, 2026 - IRVINE, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) ...

1 000 millions d’euros d’obligations à taux fixe, échéance mai 2029, portant intérêt au taux annuel de 3,000%  650 millions d’euros d’obligations à taux fixe, échéance mai 2033, portant intérêt au tau ...